Opinion

Video

Reducing Treatment Burden in IBD with At-Home Therapy Options

Author(s):

Jean-Frederic Colombel, MD

Jean-Frederic Colombel, MD, offers insights into subcutaneous infliximab-dyyb injection, detailing its administration and approved indications for ulcerative colitis and Crohn's disease.

  1. The FDA has now approved a subcutaneous infliximab injection for IBD. Can you provide an overview of subcutaneous infliximab-dyyb injection? What is the significance of this approval?
    1. How could this impact patients with UC and CD?
  2. What are the indications for subcutaneous infliximab-dyyb injection?
    1. When and how can this therapy be started?
Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Related Content
Study Identifies Homelessness as a Predictor Against Clozapine Use
November 22nd 2024

Study Identifies Homelessness as a Predictor Against Clozapine Use

Chelsie Derman
Medical Ethics Unpacked: Ethical Considerations for Euthanasia and Medically-Assisted Suicide
November 22nd 2024

Medical Ethics Unpacked: Ethical Considerations for Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Esi Lamousé-Smith, MD, PhD | Credit: Johnson & Johnson
November 22nd 2024

J&J Submits sBLA for Guselkumab (Tremfya) Subcutaneous Induction Regimen in UC

Abigail Brooks, MA
Medical Ethics Unpacked:
November 22nd 2024

Medical Ethics Unpacked: Ethical Foundations and Background of Euthanasia & Medically-Assisted Suicide

Steven Levine, MD Dominic Sisti, PhD
Study Highlights Wound Closure Techniques Following Wide Excision for HS
November 22nd 2024

Study Highlights Wound Closure Techniques Following Wide Excision for HS

Tim Smith
Orrin Troum, MD, clinical professor of medicine, Keck School of Medicine, University of Southern California, and director, clinical rheumatology research, Providence St John's Hospital, Santa Monica, California
November 22nd 2024

Shortened Pegloticase Infusions Feasible for Uncontrolled Gout, Reduces Treatment Burden

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.